The fund seeks primarily dividend income and capital appreciation in the long term and secondarily dividend growth by investing in companies across any size outside the United States.

The investment process starts with a list of companies in the benchmark index and the research team utilizes quantitative techniques and fundamental analysis to identify investment opportunities.

Next, the research team invests in domestic and foreign securities across all market capitalizations and economic sectors without limitation.

However, the team prefers investing in the securities of dividend paying companies.

The research process is driven by fundamental analysis of one stock at a time. In selecting securities for the portfolio, the research team focuses on companies that represent above-average long-term investment opportunities or have significant near-term appreciation potential.

The team favors attractively-valued companies that provide attractive current income, have income and capital appreciation potential, and/or reduce overall portfolio volatility.

In addition, the team utilizes its proprietary values-based screening processes to narrow the investable universe.

The team focuses on companies that reflect values such as respecting the value and freedom of all people, demonstrating a concern for justice and peace, promoting family and community, exhibiting responsible management practices, and practicing environmental stewardship.

Additionally, the team may invest in securities that fund community development institutions and serve needs such as those of low-to-moderate income families and communities.

Then the manager constructs a portfolio of stocks from a list of companies favored by the research team and allocates capital based on its conviction level.

The fund’s investments in foreign securities may be made either directly or through American Depository Receipts.

Also, the fund may invest in other securities such as yieldcos, real estate investment trusts, convertible bonds, preferred stocks, and master limited partnerships.

The fund may invest up to 15% of its net assets in companies whose securities may have legal or contractual restrictions on resale or are otherwise illiquid.

The fund seeks capital appreciation in the long term by investing in companies across any size in the United States.

The investment process starts with a list of companies in the benchmark index and the research team utilizes quantitative techniques and fundamental analysis to identify investment opportunities.

Next, the research team invests in a broad range of equity securities.

The team favors companies with financial strengths and outlook.

In addition, the team utilizes its proprietary values-based screening processes to narrow the investable universe.

The team focuses on companies that reflect values such as respecting the value and freedom of all people, demonstrating a concern for justice and peace, promoting family and community, exhibiting responsible management practices, and practicing environmental stewardship.

Additionally, the team may invest in securities that fund community development institutions and serve needs such as those of low-to-moderate income families and communities.

Then the manager constructs a portfolio of stocks from a list of companies favored by the research team and allocates capital based on its conviction level.

From time to time, the fund may invest a substantial portion of its net assets in the stock of companies in the technology, industrial, healthcare and life sciences sectors.

The fund may invest without limitation in securities in companies domiciled outside the United States either directly or through American Depositary Receipts.

Also, the fund may invest up to 15% of its net assets in companies whose securities may have legal or contractual restrictions on resale or are otherwise illiquid.

Additionally, the fund may invest in development stage companies.

The fund seeks capital appreciation in the long term by investing in companies across any size in the United States.

The investment process is relies on fundamental analysis to identify companies in healthcare and life sciences companies.

Healthcare and life sciences companies include those companies that derive or are expected to derive 50% or more of their revenue from healthcare and life science products and services including, but not limited to, biotechnology, pharmaceuticals, diagnostics, life science tools, medical devices, healthcare information technology, healthcare services, synthetic biology, agricultural and environmental management, and pharmaceutical manufacturing products and services.

Next, the research team focuses on companies with attractive valuations exhibiting above-average long-term investment opportunities or significant near-term appreciation potential.

Then the manager constructs a portfolio from a list of companies in the benchmark index favored by the research team and allocates capital based on its conviction level.

The manager invests over 25% of the fund’s net assets in drug related industries. This group of industries includes pharmaceutical, biotech and similar companies that primarily develop, produce or distribute drugs, medicines, diagnostic chemicals and biological products used to diagnose, prevent or treat diseases or maintain health.

The fund invests in companies that demonstrate values and business practices that are ethical, sustainable, and provide an attractive investment opportunity.

The fund looks for companies that respect the value and freedom of all people, demonstrate a concern for justice and peace, promote family and community, demonstrate responsible management practices, and practice environmental stewardship.

However, the fund may invest in companies that fund community development institutions and serve needs of low-to-moderate income families and communities.

The fund may invest without limitation in companies domiciled outside the United States either directly or through American Depositary Receipts.